Registry and biospecimen collection for hidradenitis suppurativa
Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
University of California, San Francisco · NCT04115566
This study is collecting information from people with hidradenitis suppurativa to better understand the condition and find new treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 10 Years and up |
| Sex | All |
| Sponsor | University of California, San Francisco (other) |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT04115566 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather comprehensive clinical and biological data on hidradenitis suppurativa (HS), a debilitating skin condition that is not well understood. By enrolling participants diagnosed with HS, the study will create a registry that characterizes the disease's features and outcomes. The collected data will help in developing a clinical classification system and identifying potential treatment options for HS. The study will include individuals aged 10 and older who can provide informed consent.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 10 and older diagnosed with hidradenitis suppurativa by a qualified healthcare professional.
Not a fit: Patients who are unable to provide informed consent or do not have a diagnosis of hidradenitis suppurativa will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and treatment options for patients with hidradenitis suppurativa.
How similar studies have performed: While there is limited research specifically on hidradenitis suppurativa, similar observational studies in other dermatological conditions have shown success in improving understanding and treatment options.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female ≥ 10 years of age 2. Diagnosis of HS by a dermatologist or practitioner experienced in making a diagnosis of HS 3. Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study. Exclusion Criteria: 1\. Inability to give informed consent or unavailability of a parent/guardian who is able and willing to give informed consent.
Where this trial is running
San Francisco, California
- University of California San Francisco — San Francisco, California, United States (RECRUITING)
Study contacts
- Principal investigator: Haley B Naik, MD, MHSc, FAAD — University of California, San Francisco
- Study coordinator: Kaelin Chatterley
- Email: hsprogress@ucsf.edu
- Phone: 415-961-3786
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hidradenitis Suppurativa